Skip to main content
. 2022 May 16;4(7):e532–e541. doi: 10.1016/S2589-7500(22)00048-6

Table.

Characteristics of the three-site cohort used for model training and testing

Attended a long COVID clinic
Did not attend a long COVID clinic
Hospitalised (n=428) Not hospitalised (n=169) Hospitalised (n=15 193) Not hospitalised (n=58 182)
Sex
Female 237 (55·4%) 127 (75·1%) 8465* (55·7%) 34 771 (59·8%)
Male 191 (44·6%) 42 (24·9%) 6716* (44·2%) 23 258 (40·0%)
Unknown 0 0 <20 153 (0·3%)
Race
Asian <20 <20 571 (3·8%) 1361 (2·3%)
Black 190 (44·4%) 31 (18·3%) 3207 (21·1%) 6370 (10·9%)
Native Hawaiian or Pacific Islander <20 <20 43 (0·3%) 138 (0·2%)
Other <20 <20 85 (0·6%) 254 (0·4%)
Unknown 81 (18·9%) 27 (16·0%) 2695 (17·7%) 9842 (16·9%)
White 142 (33·2%) 107 (63·3%) 8592 (56·6%) 40 217 (69·1%)
Ethnicity
Hispanic or Latino 69* (16·1%) 26* (15·4%) 3064 (20·2%) 11 416 (19·6%)
Not Hispanic or Latino 354* (82·7%) 128* (75·7%) 11 869 (78·1%) 45 119 (77·5%)
Unknown <20 <20 260 (1·7%) 1647 (2·8%)
Age, years
18–25 <20 <20 790 (5·2%) 7573 (13·0%)
26–45 86* (20·1%) 75 (44·4%) 3824 (25·2%) 22 732 (39·1%)
46–65 188* (43·9%) 69 (40·8%) 5249 (34·5%) 19 015 (32·7%)
≥66 147* (34·3%) <20 5330 (35·1%) 8862 (15·2%)
Mean age (SD) 58·29 (15·03) 48·14 (14·02) 56·50 (18·60) 45·92 (17·32)
Pre-COVID-19 comorbidities
Diabetes 86 (20·1%) <20 2412 (15·9%) 4842 (8·3%)
Chronic kidney disease 70 (16·4%) <20 1721 (11·3%) 2272 (3·9%)
Congestive heart failure 48 (11·2%) <20 960 (6·3%) 1133 (1·9%)
Chronic pulmonary disease 45 (10·5%) 29 (17·2%) 1415 (9·3%) 3698 (6·4%)

Data are n (%) unless otherwise stated. All patients shown had acute COVID-19. Diabetes was not separated by type.

*

In accordance with the N3C download policy,21 for demographics where small cell sizes (<20 patients) could be derived from context, we have shifted the counts by a random number between 1 and 5. The accompanying percentages reflect the shifted number.